Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)
CUSIP: 221015100
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 91,091,040
- Total 13F shares
- 21,363,573
- Share change
- -718,262
- Total reported value
- $18,157,963
- Put/Call ratio
- 9.9%
- Price per share
- $0.85
- Number of holders
- 38
- Value change
- -$606,364
- Number of buys
- 12
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 221015100?
CUSIP 221015100 identifies CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 221015100:
Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
7.6%
|
6,943,654
|
$5,683,000 | — | 30 Sep 2022 | |
| ADAMS STREET PARTNERS LLC |
13F
3/4/5
|
Company · 10%+ Owner |
3.6%
|
3,275,616
|
$2,683,000 | — | 30 Sep 2022 | |
| CHI Advisors LLC |
13F
|
Company |
2.6%
|
2,384,402
|
$1,952,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.5%
|
2,265,312
|
$1,854,000 | — | 30 Sep 2022 | |
| BVF INC/IL |
13F
|
Company |
1.5%
|
1,370,947
|
$1,122,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
1,259,906
|
$1,031,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
975,519
|
$798,000 | — | 30 Sep 2022 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.57%
|
522,009
|
$427,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.55%
|
502,942
|
$411,000 | — | 30 Sep 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.55%
|
500,000
|
$409,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.53%
|
480,100
|
$393,000 | — | 30 Sep 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.47%
|
429,708
|
$352,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
298,460
|
$244,000 | — | 30 Sep 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
159,300
|
$130,000 | — | 30 Sep 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.16%
|
142,160
|
$115,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
112,603
|
$92,000 | — | 30 Sep 2022 | |
| EcoR1 Capital, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
81,077
|
$64,051 | — | 30 Sep 2021 | |
| JACKSON SQUARE CAPITAL, LLC |
13F
|
Company |
0.07%
|
63,773
|
$52,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
52,168
|
$43,000 | — | 30 Sep 2022 | |
| Hikari Power Ltd |
13F
|
Company |
0.05%
|
49,959
|
$41,000 | — | 30 Sep 2022 | |
| BAILARD, INC. |
13F
|
Company |
0.04%
|
39,998
|
$33,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
38,800
|
$32,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
37,051
|
$30,000 | — | 30 Sep 2022 | |
| LMR Partners LLP |
13F
|
Company |
0.03%
|
30,000
|
$25,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
22,110
|
$18,000 | — | 30 Sep 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
20,775
|
$17,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
17,261
|
$14,000 | — | 30 Sep 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.02%
|
16,050
|
$13,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.02%
|
13,790
|
$11,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
11,668
|
$10,000 | — | 30 Sep 2022 | |
| MERCER GLOBAL ADVISORS INC /ADV |
13F
|
Company |
0.01%
|
10,550
|
$9,000 | — | 30 Sep 2022 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
10,500
|
$9,000 | — | 30 Sep 2022 | |
| Leonteq Securities AG |
13F
|
Company |
0.01%
|
10,000
|
$8,185 | — | 30 Sep 2022 | |
| WOLVERINE TRADING, LLC |
13F
|
Company |
0.01%
|
10,688
|
$8,000 | — | 30 Sep 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
7,049
|
$6,000 | — | 30 Sep 2022 | |
| WHITTIER TRUST CO OF NEVADA INC |
13F
|
Company |
0%
|
4,200
|
$3,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,786
|
$2,000 | — | 30 Sep 2022 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0%
|
1,750
|
$1,000 | — | 30 Sep 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,100
|
$1,000 | — | 30 Sep 2022 | |
| TCI Wealth Advisors, Inc. |
13F
|
Company |
0%
|
800
|
$1,000 | — | 30 Sep 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
99
|
$81 | — | 30 Sep 2022 |
Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q4 2022
As of 31 Dec 2022,
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,363,573 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, CHI Advisors LLC, MILLENNIUM MANAGEMENT LLC, BVF INC/IL, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, Artal Group S.A., and BlackRock Inc..
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
38
Q4 2022 holders
38
Holder diff
0
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.